Published on
July 8, 2024

What We Read in June 2024

Written by:
Reviewed by:
No items found.
3 min

What We Read in June 2024

Published on
July 25, 2025
Written by:
Reviewed by:
No items found.
Share

Staying informed about the latest developments in cognitive impairment, dementia care and brain health is crucial. The Sunday Health team frequently shares articles with one another to deepen our understanding, expand our knowledge and keep a pulse on what is happening in the field and we wanted to take a moment to share what we've been reading over the past couple of weeks with you!

Whether you're a caregiver, healthcare professional, or someone interested in brain health, we hope these articles will be helpful and informative.

What we read in June 2024

Lifestyle changes may slow or improve Alzheimer’s and dementia, study finds | CNN

Following a vegan diet, reducing stress, exercising and sharing feelings with others helped people slow the progression of Alzheimer’s disease, a new study found.

Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's Disease | FDA

Once-monthly Kisunla is the first and only amyloid plaque-targeting therapy with evidence to support stopping therapy when amyloid plaques are removed, which can result in lower treatment costs and fewer infusions.

Alzheimer’s Takes a Financial Toll Long Before Diagnosis, Study Finds | The New York Times

New research shows that people who develop dementia often begin falling behind on bills years earlier.

New Help for Dealing With Aggression in People With Dementia | KFF Health News.

A free online tool offers free training in a comprehensive approach to managing neuropsychiatric symptoms of dementia.

The Path Bill Gates Sees to Overcoming Alzheimer’s Biggest Remaining Challenges | Scientific American

Gates talks about his own experience as a caregiver and all he is doing to fight this disease.

Join the conversation

For more updates and resources, follow Sunday Health on LinkedIn, Instagram, and Facebook.